Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025)

Pulmonx (LUNG) has disclosed Depreciation & Amortization (CF) for 7 consecutive years, with $246000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 34.57% to $246000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 24.83% decrease, with the full-year FY2024 number at $1.5 million, down 3.55% from a year prior.
  • Depreciation & Amortization (CF) was $246000.0 for Q3 2025 at Pulmonx, down from $299000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $437000.0 in Q1 2023 to a low of $141000.0 in Q1 2021.
  • A 5-year average of $328631.6 and a median of $374000.0 in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 192.19% in 2021, then crashed 34.57% in 2025.
  • Pulmonx's Depreciation & Amortization (CF) stood at $374000.0 in 2021, then rose by 3.21% to $386000.0 in 2022, then decreased by 25.65% to $287000.0 in 2023, then increased by 2.44% to $294000.0 in 2024, then decreased by 16.33% to $246000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Depreciation & Amortization (CF) are $246000.0 (Q3 2025), $299000.0 (Q2 2025), and $278000.0 (Q1 2025).